# Integra Lifesciences Holdings Corp: Form 8-K, filed Nov 4, 2024

- Company: [Integra Lifesciences Holdings Corp](/companies/iart.md) (CIK 917520)
- Form: 8-K
- Filed: 2024-11-04
- Accepted by EDGAR: Nov 4, 2024, 06:15 ET
- Period: 2024-11-04
- Accession: 0000917520-24-000105
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/iart-20241104.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/917520/000091752024000105/iart-20241104.htm

Filed Nov 4, 2024.
Source: SEC EDGAR, the filing index for accession 0000917520-24-000105. Last ingested by Listed: Nov 11, 2026, 00:10 ET. No prices; not investment advice.
